Filtered By:
Specialty: Cardiology
Procedure: Angioplasty
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 2169 results found since Jan 2013.
The effect of nicorandil on cardiac function and clinical outcomes in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a randomised trial
CONCLUSIONS: Treatment with nicorandil for 6 months after primary PCI was not associated with any improvement in infarct size, CMR-determined cardiac function, and outcomes in STEMI patients.PMID:36942830 | DOI:10.1080/00015385.2022.2129592
Source: Acta Cardiologica - March 21, 2023 Category: Cardiology Authors: Jeong Cheon Choe Jun-Hyok Oh Han Cheol Lee Ji Won Lee Tae Sik Park Jong Ha Park La Eun Kim Min Su Kim Jinhee Ahn Jin Sup Park Hye Won Lee Jung Hyun Choi Kwang Soo Cha Source Type: research
Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Polish Heart Journal - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research
Clinical Characteristics and Outcomes of Chinese Patients with Premature Acute Coronary Syndrome
This study aimed to investigate the clinical characteristics and major adverse cardiovascular events (MACEs) of Chinese patients with premature acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). This study was a secondary retrospective analysis involving 2114 ACS patients undergoing PCI at a single center in China. The patients were divided into two groups according to age (premature ACS group: ≤ 55 years in men, ≤ 65 years in women; nonpremature ACS group: > 55 years in men, > 65 years in women). The primary endpoint was all-cause death, and the secondary endpoint was a composite ...
Source: International Heart Journal - March 17, 2023 Category: Cardiology Authors: Jian-Di Liu Ren Gong Jin-Song Xu Shi-Yuan Zhang Yan-Qing Wu Source Type: research
Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Kardiologia Polska - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research
Clinical Characteristics and Outcomes of Chinese Patients with Premature Acute Coronary Syndrome
This study aimed to investigate the clinical characteristics and major adverse cardiovascular events (MACEs) of Chinese patients with premature acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). This study was a secondary retrospective analysis involving 2114 ACS patients undergoing PCI at a single center in China. The patients were divided into two groups according to age (premature ACS group: ≤ 55 years in men, ≤ 65 years in women; nonpremature ACS group: > 55 years in men, > 65 years in women). The primary endpoint was all-cause death, and the secondary endpoint was a composite ...
Source: International Heart Journal - March 17, 2023 Category: Cardiology Authors: Jian-Di Liu Ren Gong Jin-Song Xu Shi-Yuan Zhang Yan-Qing Wu Source Type: research
Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Kardiologia Polska - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research
Clinical Characteristics and Outcomes of Chinese Patients with Premature Acute Coronary Syndrome
This study aimed to investigate the clinical characteristics and major adverse cardiovascular events (MACEs) of Chinese patients with premature acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). This study was a secondary retrospective analysis involving 2114 ACS patients undergoing PCI at a single center in China. The patients were divided into two groups according to age (premature ACS group: ≤ 55 years in men, ≤ 65 years in women; nonpremature ACS group: > 55 years in men, > 65 years in women). The primary endpoint was all-cause death, and the secondary endpoint was a composite ...
Source: International Heart Journal - March 17, 2023 Category: Cardiology Authors: Jian-Di Liu Ren Gong Jin-Song Xu Shi-Yuan Zhang Yan-Qing Wu Source Type: research
Safety and feasibility of minimally invasive coronary artery bypass surgery early after drug eluting stent implantation due to acute coronary syndrome
CONCLUSIONS: EACAB is a safe and feasible method of LAD revascularization in patients who received DES for ACS within 180 days prior to surgery, despite early dual antiplatelet therapy discontinuation. The adverse event rate is low and acceptable.PMID:36929299 | DOI:10.33963/KP.a2023.0066
Source: Polish Heart Journal - March 17, 2023 Category: Cardiology Authors: Krzysztof Sanetra Piotr P Buszman Piotr P Buszman Justyna Jankowska-Sanetra Justyna Jankowska-Sanetra Marta Konopko Marta Konopko Monika Slabon-Turska Monika Slabon-Turska Krzysztof Bia łek Krzysztof Bia łek Krzysztof Milewski Krzysztof Milewski Witold Source Type: research
